What does Shanghai Shen Lian Biomedical Corporation do?

Shanghai Shen Lian Biomedical Corporation (688098.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 688098.SS's market cap?

Shanghai Shen Lian Biomedical Corporation (688098.SS) has a market capitalization of approximately $3.39 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 688098.SS pay a dividend?

Yes — Shanghai Shen Lian Biomedical Corporation (688098.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 688098.SS profitable?

Shanghai Shen Lian Biomedical Corporation (688098.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

688098.SS

Shanghai Shen Lian Biomedical Corporation

SHH·Biotechnology · Healthcare

¥8.26¥0.04+0.49%

Market cap¥3.39B·Market closed·Aug 27 5:53 AM UTC

Price Chart

¥8.26+¥0.04 (+0.49%)today

−33.65%CAGR −7.88%

Select date range

FromTo

Oct 28, 2019Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.035

Ex-Dividend DateJun 14

Payment DateJun 14

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 16

Last Report DateApr 28

Reported vs Estimate−¥0.05

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥272.12M

Net Income−¥17.80M

Net Margin−6.5%

Operating Cash Flow−¥11.22M

Capital Expenditures¥3.27M

Free Cash Flow−¥7.95M

Return on Equity−1.3%

Return on Invested Capital−0.2%

Net Cash¥69.20M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 688098.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 688098.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688098.SS and 80,000+ other tickers.

About Shanghai Shen Lian Biomedical Corporation

Shanghai Shen Lian Biomedical Corporation operates within China's animal health industry, specializing in the entire lifecycle of veterinary biological products, from initial research and development to manufacturing and sales. A primary focus for the company is the creation of advanced synthetic peptide vaccines, specifically engineered to combat foot-and-mouth disease. This enterprise was established in 2001 and is based in Shanghai, China.

CEO: Dongsheng Nie
Sector: Healthcare
Industry: Biotechnology
Exchange: SHH
Employees: 375
Website: www.slbio.com.cn

Peers

Peers Tab

603718.SS

Shanghai Hile Bio-Technology Co., Ltd.

Cap

¥2.0B

603566.SS

Pulike Biological Engineering, Inc.

Cap

¥3.5B

300858.SZ

Beijing Scitop Bio-tech Co., Ltd.

Cap

¥3.9B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 688098.SS

What does Shanghai Shen Lian Biomedical Corporation do?: Shanghai Shen Lian Biomedical Corporation (688098.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 688098.SS's market cap?: Shanghai Shen Lian Biomedical Corporation (688098.SS) has a market capitalization of approximately $3.39 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 688098.SS pay a dividend?: Yes — Shanghai Shen Lian Biomedical Corporation (688098.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 688098.SS profitable?: Shanghai Shen Lian Biomedical Corporation (688098.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.